Article info

Download PDFPDF
SHOULD CA125 RESPONSE CRITERIA BE PREFERRED TO WHO CRITERIA IN THE MONITORING OF SECOND-LINE CHEMOTHERAPY (SLC) OF EPITHELIAL OVARIAN CARCINOMA (EOC)?

Authors

Citation

Gronlund B, Hansen HH, Engelholm SA, et al
SHOULD CA125 RESPONSE CRITERIA BE PREFERRED TO WHO CRITERIA IN THE MONITORING OF SECOND-LINE CHEMOTHERAPY (SLC) OF EPITHELIAL OVARIAN CARCINOMA (EOC)?
Online issue publication 
March 12, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.